Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab

Author(s):
Heijde, D. van der; Breban, M.; Halter, D.; DiVittorio, G.; Bratt, J.; Cantini, F.; Kary, S.; Pangan, A.L.; Kupper, H.; Rathmann, S.S.; Sieper, J.; Mease, P.J.
Published
2015
Publication type
Article / Letter to editor
anti-TNF drugsankylosing spondylitisspinal mobilityhealth-related quality of lifephysical function
Date issued
2015-07-31
Language
English
Is part of
Rheumatology (2015), Vol. 54, no. 7, p. 1210-1219
hdl
1887/101643
doi
10.1093/rheumatology/keu438